Pittsburgh Biomedical Development Corpor is categorized under Health Services in Pittsburgh, PA and active since 2001.
Pittsburgh Biomedical Development Corpor was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Jerry Paytas at the company’s single location by writing to 4516 Henry St # 202, Pittsburgh, Pennsylvania PA 15213 or by phoning (412) 687-6063. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pittsburgh Biomedical Development Corpor |
| Contact Person: | Jerry Paytas |
| Address: | 4516 Henry St # 202, Pittsburgh, Pennsylvania 15213 |
| Phone Number: | (412) 687-6063 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Pittsburgh Biomedical Development Corpor was started in 2001 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jerry Paytas for inquiries that concern Pittsburgh Biomedical Development Corpor by calling the company number (412) 687-6063, as your correspondence is most welcome. Additionally, the physical location of the single location of Pittsburgh Biomedical Development Corpor can be found at the coordinates as well as the street address 4516 Henry St # 202 in Pittsburgh, Pennsylvania 15213.
For its online presence, you may visit Pittsburgh Biomedical Development Corpor’s website at and engage with its social media outlets through on Twitter and on Facebook.